DePinho re­signs top post at MD An­der­son Cancer Cen­ter in Hous­ton

Modern Healthcare - - REGIONAL NEWS - —Rachel Arndt

Dr. Ron­ald DePinho, pres­i­dent of MD An­der­son Cancer Cen­ter since 2011, is step­ping down from head­ing the fi­nan­cially trou­bled hospi­tal ef­fec­tive this May.

DePinho, 62, an­nounced his res­ig­na­tion last week in a letter to the chan­cel­lor of the Univer­sity of Texas, which runs the cen­ter. Dur­ing DePinho’s ten­ure, the hospi­tal faced lay­offs and fi­nan­cial woes, in­clud­ing a $266 mil­lion loss in fis­cal 2016 de­spite rak­ing in ap­prox­i­mately $4 bil­lion in an­nual rev­enue.

The hospi­tal was also trou­bled by agree­ments it had with out­side firms. Late last year, MD An­der­son and IBM put their part­ner­ship on hold, stalling plans to use IBM Watson for pre­ci­sion-medicine cancer treat­ment. The project, which was led by DePinho’s wife, failed to meet its goals, and a Univer­sity of Texas au­dit showed it cost MD An­der­son more than $62 mil­lion. The au­dit also noted that con­tracts MD An­der­son had with IBM and Price­wa­ter­house-Coop­ers broke in­ter­nal rules, in­clud­ing those that call for com­pet­i­tive bid­ding.

In his res­ig­na­tion letter, DePinho wrote that MD An­der­son “needs a new pres­i­dent who will in­spire greater unity and a sharp op­er­a­tional fo­cus on nav­i­gat­ing the tec­tonic changes in health­care de­liv­ery and eco­nomics.”

Dr. Ron­ald DePinho

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.